166 related articles for article (PubMed ID: 9499745)
1. Practical guidelines for the treatment of malignant gliomas.
Chamberlain MC; Kormanik PA
West J Med; 1998 Feb; 168(2):114-20. PubMed ID: 9499745
[TBL] [Abstract][Full Text] [Related]
2. Phase III randomized study of postradiotherapy chemotherapy with alpha-difluoromethylornithine-procarbazine, N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosurea, vincristine (DFMO-PCV) versus PCV for glioblastoma multiforme.
Levin VA; Uhm JH; Jaeckle KA; Choucair A; Flynn PJ; Yung WKA ; Prados MD; Bruner JM; Chang SM; Kyritsis AP; Gleason MJ; Hess KR
Clin Cancer Res; 2000 Oct; 6(10):3878-84. PubMed ID: 11051233
[TBL] [Abstract][Full Text] [Related]
3. [Prognostic factors in malignant gliomas].
Ushio Y; Kochi M
Gan To Kagaku Ryoho; 1996 Apr; 23(5):643-8. PubMed ID: 8678527
[TBL] [Abstract][Full Text] [Related]
4. Phase III randomized study of postradiotherapy chemotherapy with combination alpha-difluoromethylornithine-PCV versus PCV for anaplastic gliomas.
Levin VA; Hess KR; Choucair A; Flynn PJ; Jaeckle KA; Kyritsis AP; Yung WK; Prados MD; Bruner JM; Ictech S; Gleason MJ; Kim HW
Clin Cancer Res; 2003 Mar; 9(3):981-90. PubMed ID: 12631596
[TBL] [Abstract][Full Text] [Related]
5. [Chemotherapy of recurrent supratentorial malignant gliomas (phase II study)].
Afra D; Sipos L; Vitanovics D
Ideggyogy Sz; 2002 Jan; 55(1-2):38-44. PubMed ID: 12122942
[TBL] [Abstract][Full Text] [Related]
6. Controlled study with BCNU vs. CCNU as adjuvant chemotherapy following surgery plus radiotherapy for glioblastoma multiforme.
Solero CL; Monfardini S; Brambilla C; Vaghi A; Valagussa P; Morello G; Bonadonna G
Cancer Clin Trials; 1979; 2(1):43-8. PubMed ID: 229983
[TBL] [Abstract][Full Text] [Related]
7. [Chemo-radiotherapy for malignant brain tumors].
Kochi M; Ushio Y
Gan To Kagaku Ryoho; 2002 May; 29(5):669-76. PubMed ID: 12040669
[TBL] [Abstract][Full Text] [Related]
8. Radiochemotherapy of malignant glioma in adults. Clinical experiences.
Kortmann RD; Jeremic B; Weller M; Plasswilm L; Bamberg M
Strahlenther Onkol; 2003 Apr; 179(4):219-32. PubMed ID: 12707711
[TBL] [Abstract][Full Text] [Related]
9. Radiotherapy plus concurrent and adjuvant procarbazine, lomustine, and vincristine chemotherapy for patients with malignant glioma.
Yang SH; Hong YK; Yoon SC; Kim BS; Lee YS; Lee TK; Lee KS; Jeun SS; Kim MC; Park CK
Oncol Rep; 2007 Jun; 17(6):1359-64. PubMed ID: 17487391
[TBL] [Abstract][Full Text] [Related]
10. Radiotherapy for high-grade gliomas. Does altered fractionation improve the outcome?
Nieder C; Andratschke N; Wiedenmann N; Busch R; Grosu AL; Molls M
Strahlenther Onkol; 2004 Jul; 180(7):401-7. PubMed ID: 15241527
[TBL] [Abstract][Full Text] [Related]
11. Phase III comparison of BCNU and the combination of procarbazine, CCNU, and vincristine administered after radiotherapy with hydroxyurea for malignant gliomas.
Levin VA; Wara WM; Davis RL; Vestnys P; Resser KJ; Yatsko K; Nutik S; Gutin PH; Wilson CB
J Neurosurg; 1985 Aug; 63(2):218-23. PubMed ID: 2991486
[TBL] [Abstract][Full Text] [Related]
12. The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for malignant glioma.
Tsao MN; Mehta MP; Whelan TJ; Morris DE; Hayman JA; Flickinger JC; Mills M; Rogers CL; Souhami L
Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):47-55. PubMed ID: 16111571
[TBL] [Abstract][Full Text] [Related]
13. Does chemotherapy benefit the patient with a central nervous system glioma?
Rodriguez LA; Levin VA
Oncology (Williston Park); 1987 Nov; 1(9):29-36, 40-1. PubMed ID: 3079493
[TBL] [Abstract][Full Text] [Related]
14. Phase II trial of thalidomide and carmustine for patients with recurrent high-grade gliomas.
Fine HA; Wen PY; Maher EA; Viscosi E; Batchelor T; Lakhani N; Figg WD; Purow BW; Borkowf CB
J Clin Oncol; 2003 Jun; 21(12):2299-304. PubMed ID: 12805330
[TBL] [Abstract][Full Text] [Related]
15. [Treatment modalities for malignant gliomas with reference to their pathophysiology].
Kobayashi S; Takakura K
Gan To Kagaku Ryoho; 1986 Jan; 13(1):11-7. PubMed ID: 3942392
[TBL] [Abstract][Full Text] [Related]
16. Phase III randomized study of radiotherapy plus procarbazine, lomustine, and vincristine with or without BUdR for treatment of anaplastic astrocytoma: final report of RTOG 9404.
Prados MD; Seiferheld W; Sandler HM; Buckner JC; Phillips T; Schultz C; Urtasun R; Davis R; Gutin P; Cascino TL; Greenberg HS; Curran WJ
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1147-52. PubMed ID: 15001257
[TBL] [Abstract][Full Text] [Related]
17. Modified procarbazine, CCNU, and vincristine (PCV 3) combination chemotherapy in the treatment of malignant brain tumors.
Levin VA; Edwards MS; Wright DC; Seager ML; Schimberg TP; Townsend JJ; Wilson CB
Cancer Treat Rep; 1980; 64(2-3):237-44. PubMed ID: 7407756
[TBL] [Abstract][Full Text] [Related]
18. The Brain Tumor Cooperative Group NIH Trial 87-01: a randomized comparison of surgery, external radiotherapy, and carmustine versus surgery, interstitial radiotherapy boost, external radiation therapy, and carmustine.
Selker RG; Shapiro WR; Burger P; Blackwood MS; Arena VC; Gilder JC; Malkin MG; Mealey JJ; Neal JH; Olson J; Robertson JT; Barnett GH; Bloomfield S; Albright R; Hochberg FH; Hiesiger E; Green S;
Neurosurgery; 2002 Aug; 51(2):343-55; discussion 355-7. PubMed ID: 12182772
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapy for malignant gliomas.
Kyritsis AP
Oncology (Williston Park); 1993 Sep; 7(9):93-100; discussion 103, 106. PubMed ID: 8217533
[TBL] [Abstract][Full Text] [Related]
20. A comparison of treatment results for recurrent malignant gliomas.
Nieder C; Grosu AL; Molls M
Cancer Treat Rev; 2000 Dec; 26(6):397-409. PubMed ID: 11139371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
